[EN] HETEROCYCLIC DERIVATIVES AS GPCR RECEPTOR AGONISTS<br/>[FR] DERIVES HETEROCYCLIQUES UTILISES COMME AGONISTES DES RECEPTEURS GPCR
申请人:PROSIDION LTD
公开号:WO2005061489A1
公开(公告)日:2005-07-07
Compounds of Formula (I), R1-A-V-B-R2; or pharmaceutically acceptable salts thereof, are agonists of GPR116 and are useful as regulators of satiety, e.g. for the treatment of obesity, and for the treatment of diabetes.
Synthesis and Mesomorphic Properties of 2,6-Disubstituted Tetralins
作者:Marco Cereghetti、Roman Marbet、Kuno Schleich
DOI:10.1002/hlca.19820650423
日期:1982.6.16
Synthesis and mesomorphic behavior of nine members of each of the two classes of 6-phenyl- and 2-phenyltetralins and five members of the 2-trans-cyclohexyltetralins are reported. The synthesis of one member of each class is described in detail. Besides the target compounds, more than twenty intermediates showed liquid crystalline properties; their transition temperatures are recorded (see Tables 1-6)
Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity and diabetes.
化合物式(I)或其药学上可接受的盐是GPCR激动剂,可用于治疗肥胖症和糖尿病。
HETEROCYCLIC DERIVATIVES AS GPCR RECEPTOR AGONISTS
申请人:Fyfe Matthew
公开号:US20090281060A1
公开(公告)日:2009-11-12
Compounds of Formula (I), R
1
-A-V—B—R
2
; or pharmaceutically acceptable salts thereof, are agonists of GPR116 and are useful as regulators of satiety, e.g. for the treatment of obesity, and for the treatment of diabetes.